A UNITED STATES CLAIMS DATABASE ANALYSIS COMPARING SAFETY, MEDICAL RESOURCE UTILIZATION, AND TREATMENT COSTS ASSOCIATED WITH THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASE BY DRUG CLASS

GrĂ¡inne H. Long  1     Amanda R. Tatro  2     Young S. Oh  2     Sheila Reiss Reddy  3     Ashwin N. Ananthakrishnan  4    
1 Roche Pharmaceuticals Ltd.,Welwyn Garden City,United Kingdom
2 Genentech, Inc.,South San Francisco,United States of America
3 Partnership for Health Analytic Research,Beverly Hills,United States of America
4 Massachusetts General Hospital and Harvard Medical School,Boston,Unite

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing